{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T17:11:14Z","timestamp":1777396274590,"version":"3.51.4"},"reference-count":44,"publisher":"SAGE Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2018,9,11]]},"DOI":"10.3233\/jad-180232","type":"journal-article","created":{"date-parts":[[2018,7,31]],"date-time":"2018-07-31T18:20:00Z","timestamp":1533061200000},"page":"765-779","source":"Crossref","is-referenced-by-count":16,"title":["Usefulness of Dual-Point Amyloid PET Scans in Appropriate Use Criteria: A Multicenter Study"],"prefix":"10.1177","volume":"65","author":[{"given":"Ferm\u00edn","family":"Segovia","sequence":"first","affiliation":[{"name":"Department of Signal Theory, Networking and Communications, University of Granada, Granada, Spain"},{"name":"DASCI Institute, University of Granada, Granada, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"G\u00f3mez-R\u00edo","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, \u201cVirgen de las Nieves\u201d University Hospital, Granada, Spain"},{"name":"Biosanitary Investigation Institute of Granada, Granada, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel","family":"S\u00e1nchez-Va\u00f1\u00f3","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, \u201c9 de Octubre\u201d Hospital, Valencia, Spain"},{"name":"Clinical Medicine and Public Health Doctoral Program of the University of Granada, Granada, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Manuel","family":"G\u00f3rriz","sequence":"additional","affiliation":[{"name":"Department of Signal Theory, Networking and Communications, University of Granada, Granada, Spain"},{"name":"DASCI Institute, University of Granada, Granada, Spain"},{"name":"Biosanitary Investigation Institute of Granada, Granada, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Ram\u00edrez","sequence":"additional","affiliation":[{"name":"Department of Signal Theory, Networking and Communications, University of Granada, Granada, Spain"},{"name":"DASCI Institute, University of Granada, Granada, Spain"},{"name":"Biosanitary Investigation Institute of Granada, Granada, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Trivi\u00f1o-Ib\u00e1\u00f1ez","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, \u201cVirgen de las Nieves\u201d University Hospital, Granada, Spain"},{"name":"Biosanitary Investigation Institute of Granada, Granada, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Crist\u00f3bal","family":"Carnero-Pardo","sequence":"additional","affiliation":[{"name":"Biosanitary Investigation Institute of Granada, Granada, Spain"},{"name":"Department of Neurology, \u201cVirgen de las Nieves\u201d University Hospital, Granada, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Dolores","family":"Mart\u00ednez-Lozano","sequence":"additional","affiliation":[{"name":"Department of Neurology, \u201cLa Magdalena\u201d Hospital, Castell\u00f3n, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Sopena-Novales","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, \u201c9 de Octubre\u201d Hospital, Valencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-180232_ref1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-180232_ref2","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","article-title":"Advancing research diagnostic criteria for Alzheimer\u2019s disease: The IWG-2 criteria","volume":"13","author":"Dubois","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-180232_ref3","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jalz.2016.02.002","article-title":"Preclinical Alzheimer\u2019s disease: Definition, natural history, and diagnostic criteria","volume":"12","author":"Dubois","year":"2016","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-180232_ref4","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol Med"},{"key":"10.3233\/JAD-180232_ref5","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1212\/WNL.0000000000002923","article-title":"A\/T\/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers","volume":"87","author":"Jack","year":"2016","journal-title":"Neurology"},{"key":"10.3233\/JAD-180232_ref6","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.neuroimage.2009.05.037","article-title":"Neural correlates of Alzheimer\u2019s disease and mild cognitive impairment: A systematic and quantitative meta-analysis involving 1351 patients","volume":"47","author":"Schroeter","year":"2009","journal-title":"Neuroimage"},{"key":"10.3233\/JAD-180232_ref7","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.2967\/jnumed.115.168732","article-title":"Comparison of early-phase 11C-deuterium-l-deprenyl and 11C-Pittsburgh Compound B PET for assessing brain perfusion in Alzheimer Disease","volume":"57","author":"Rodriguez-Vieitez","year":"2016","journal-title":"J Nucl Med"},{"key":"10.3233\/JAD-180232_ref8","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00259-011-2051-2","article-title":"Correlation of early-phase 18F-florbetapir (AV-45\/Amyvid) PET images to FDG images: Preliminary studies","volume":"39","author":"Hsiao","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.3233\/JAD-180232_ref9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S1474-4422(08)70001-2","article-title":"Imaging of amyloid \u03b2 in Alzheimer\u2019s disease with 18F-BAY94-9172, a novel PET tracer: Proof of mechanism","volume":"7","author":"Rowe","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-180232_ref10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.nicl.2016.10.005","article-title":"Evaluation of early-phase [18F]-florbetaben PET acquisition in clinical routine cases","volume":"14","author":"Daerr","year":"2016","journal-title":"Neuroimage Clin"},{"key":"10.3233\/JAD-180232_ref11","first-page":"1849","article-title":"Amyloid-PET imaging in clinical routine cases","volume":"55","author":"Oestreicher","year":"2014","journal-title":"J Nucl Med"},{"key":"10.3233\/JAD-180232_ref12","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1007\/s00259-016-3353-1","article-title":"Early 18F-florbetaben and 11C-PiB PET images are a surrogate biomarker of neuronal injury in Alzheimer\u2019s disease","volume":"43","author":"Tiepolt","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.3233\/JAD-180232_ref13","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.2967\/jnumed.117.200964","article-title":"Validation of non-invasive tracer kinetic analysis of 18F-Florbetaben PET using a dual time-window acquisition protocol","volume":"59","author":"Bullich","year":"2018","journal-title":"J Nucl Med"},{"key":"10.3233\/JAD-180232_ref14","doi-asserted-by":"crossref","first-page":"723","DOI":"10.2967\/jnumed.112.107185","article-title":"PET quantification of 18F-Florbetaben binding to \u03b2-amyloid deposits in human brains","volume":"54","author":"Becker","year":"2013","journal-title":"J Nucl Med"},{"key":"10.3233\/JAD-180232_ref15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s40336-015-0102-6","article-title":"Beta-amyloid imaging with florbetaben","volume":"3","author":"Sabri","year":"2015","journal-title":"Clin Transl Imaging"},{"key":"10.3233\/JAD-180232_ref16","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1007\/s00259-016-3426-1","article-title":"Dual-phase amyloid PET: Hitting two birds with one stone","volume":"43","author":"Garibotto","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.3233\/JAD-180232_ref17","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.2967\/jnumed.113.127068","article-title":"Update on appropriate use criteria for amyloid PET imaging: Dementia experts, mild cognitive impairment, and education","volume":"54","author":"Johnson","year":"2013","journal-title":"J Nucl Med"},{"key":"10.3233\/JAD-180232_ref18","first-page":"303","article-title":"Recomendaciones para la utilizaci\u00f3n de biomarcadores de imagen PET en el proceso diagn\u00f3stico de las enfermedades neurodegenerativas que cursan con demencia: Documento de consenso SEMNIM y SEN","volume":"34","author":"Arbizu","year":"2015","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"key":"10.3233\/JAD-180232_ref19","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jalz.2016.03.002","article-title":"Testing and disclosures related to amyloid imaging and Alzheimer\u2019s disease: Common questions and fact sheet summary","volume":"12","author":"Rabinovici","year":"2016","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-180232_ref20","first-page":"860","article-title":"Utilidad diagn\u00f3stica del Test de las Fotos (Fototest) en el deterioro cognitivo y demencia","volume":"22","author":"Carnero Pardo","year":"2007","journal-title":"Neurolog\u00eda"},{"key":"10.3233\/JAD-180232_ref21","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1007\/s00259-009-1264-0","article-title":"EANM procedure guidelines for PET brain imaging using 18F-FDG, version 2","volume":"36","author":"Varrone","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.3233\/JAD-180232_ref22","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/978-3-540-69384-0_79","volume-title":"Computational Science - ICCS 2008","author":"Ram\u00edrez","year":"2008"},{"key":"10.3233\/JAD-180232_ref23","volume-title":"Statistical Parametric Mapping: The Analysis of Functional Brain Images","author":"Friston","year":"2006"},{"key":"10.3233\/JAD-180232_ref24","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.neuroimage.2005.02.018","article-title":"Unified segmentation","volume":"26","author":"Ashburner","year":"2005","journal-title":"Neuroimage"},{"key":"10.3233\/JAD-180232_ref25","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.neuroimage.2012.10.005","article-title":"Linear intensity normalization of FP-CIT SPECT brain images using the \u03b1-stable distribution","volume":"65","author":"Salas-Gonzalez","year":"2013","journal-title":"Neuroimage"},{"key":"10.3233\/JAD-180232_ref26","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.2967\/jnumed.116.187351","article-title":"Optimal reference region to measure longitudinal amyloid-beta change with 18F-Florbetaben PET","volume":"58","author":"Bullich","year":"2017","journal-title":"J Nucl Med"},{"key":"10.3233\/JAD-180232_ref27","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.2967\/jnumed.116.174615","article-title":"SNMMI Procedure Standard\/EANM Practice Guideline for Amyloid PET Imaging of the Brain 1.0","volume":"57","author":"Minoshima","year":"2016","journal-title":"J Nucl Med"},{"key":"10.3233\/JAD-180232_ref28","doi-asserted-by":"crossref","first-page":"815","DOI":"10.3233\/JAD-142229","article-title":"Visual versus semi-quantitative analysis of 18F-FDG-PET in amnestic MCI: An European Alzheimer\u2019s Disease Consortium (EADC) Project","volume":"44","author":"Morbelli","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-180232_ref29","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1006\/nimg.2001.0978","article-title":"Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain","volume":"15","author":"Tzourio-Mazoyer","year":"2002","journal-title":"Neuroimage"},{"key":"10.3233\/JAD-180232_ref30","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/B978-012372560-8\/50002-4","article-title":"Chapter 02 - Statistical parametric mapping","author":"Friston","year":"2007","journal-title":"Statistical Parametric Mapping"},{"key":"10.3233\/JAD-180232_ref31","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/B978-012372560-8\/50010-3","article-title":"Chapter 10 - Covariance Components","author":"Glaser","year":"2007","journal-title":"Statistical Parametric Mapping"},{"key":"10.3233\/JAD-180232_ref32","first-page":"307","article-title":"Measurement in medicine: The analysis of method comparison studies","volume":"32","author":"Altman","year":"1983","journal-title":"J R Stat Soc Series D Stat"},{"key":"10.3233\/JAD-180232_ref33","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1177\/0271678X16645593","article-title":"Comparability of [18F]THK5317 and [11C]PIB blood flow proxy images with [18F]FDG positron emission tomography in Alzheimer\u2019s disease","volume":"37","author":"Rodriguez-Vieitez","year":"2017","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.3233\/JAD-180232_ref34","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1007\/s00259-016-3359-8","article-title":"Imaging characteristic of dual-phase 18F-florbetapir (AV-45\/Amyvid) PET for the concomitant detection of perfusion deficits and beta-amyloid deposition in Alzheimer\u2019s disease and mild cognitive impairment","volume":"43","author":"Lin","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.3233\/JAD-180232_ref35","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.bbadis.2011.11.006","article-title":"The use of PIB-PET as a dual pathological and functional biomarker in AD","volume":"1822","author":"Forsberg","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.3233\/JAD-180232_ref36","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/cercor\/bhn087","article-title":"Regional differences in the coupling between resting cerebral blood flow and metabolism may indicate action preparedness as a default state","volume":"19","author":"Gur","year":"2009","journal-title":"Cereb Cortex"},{"key":"10.3233\/JAD-180232_ref37","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2385-6-4","article-title":"A statistical investigation of normal regional intra-subject heterogeneity of brain metabolism and perfusion by F-18 FDG and O-15 H2O PET imaging","volume":"6","author":"Wong","year":"2006","journal-title":"BMC Nucl Med"},{"key":"10.3233\/JAD-180232_ref38","first-page":"594","article-title":"Brain 18F-FDG PET in the diagnosis of neurodegenerative dementias: Comparison with perfusion SPECT and with clinical evaluations lacking nuclear imaging","volume":"45","author":"Silverman","year":"2004","journal-title":"J Nucl Med"},{"key":"10.3233\/JAD-180232_ref39","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2967\/jnumed.110.082057","article-title":"Early 11C-PIB frames and 18F-FDG PET measures are comparable: A study validated in a cohort of AD and FTLD patients","volume":"52","author":"Rostomian","year":"2011","journal-title":"J Nucl Med"},{"key":"10.3233\/JAD-180232_ref40","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1212\/WNL.56.9.1143","article-title":"Practice parameter: Diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"56","author":"Knopman","year":"2001","journal-title":"Neurology"},{"key":"10.3233\/JAD-180232_ref41","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/NEN.0b013e31824b211b","article-title":"Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010","volume":"71","author":"Beach","year":"2012","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JAD-180232_ref42","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1007\/s00330-014-3311-x","article-title":"Comparison of dual-biomarker PIB-PET and dual-tracer PET in AD diagnosis","volume":"24","author":"Fu","year":"2014","journal-title":"Eur Radiol"},{"key":"10.3233\/JAD-180232_ref43","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.2967\/jnumed.108.051946","article-title":"Longitudinal cerebral blood flow and amyloid deposition: An emerging pattern?","volume":"49","author":"Sojkova","year":"2008","journal-title":"J Nucl Med"},{"key":"10.3233\/JAD-180232_ref44","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1093\/brain\/awu043","article-title":"Association of brain amyloid-\u03b2 with cerebral perfusion and structure in Alzheimer\u2019s disease and mild cognitive impairment","volume":"137","author":"Mattsson","year":"2014","journal-title":"Brain"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-180232","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:07:54Z","timestamp":1777370874000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-180232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,11]]},"references-count":44,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/jad-180232","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,11]]}}}